First Intraoperative Radiation Therapy Center in Africa: First 2 Years in Operation, Including COVID-19 ExperiencesORIGINAL REPORTS Published on 2020-11-062022-10-31 Journal: JCO Global Oncology [Category] Coronavirus, SARS, [키워드] addition addressed African age alleviate boost Breast Breast cancer Breast carcinoma Cancer center Characteristics Complication COVID-19 criteria Efficiency experience histology hospital IMPROVE include Including limitation Local Lymph node no detrimental effect offer one patient operation parenchymal Patient performed positive Radiation radiation therapy receiving reduce resulting retrospective Retrospective study Selection Seven Society Standard deviation Treatment unit viability were recorded Year [DOI] 10.1200/GO.20.00258 PMC 바로가기 [Article Type] ORIGINAL REPORTS
A Novel Human Skin Tissue Model To Study Varicella-Zoster Virus and Human Cytomegalovirus수두-대상포진 바이러스와 인간 거대세포바이러스를 연구하기 위한 새로운 인간 피부 조직 모델Article Published on 2020-10-272023-05-31 Journal: Journal of Virology [Category] Fulltext, 대상포진, 두창, 수두, 홍역, [키워드] crawl-out assay flow cytometry histology Human Cytomegalovirus SCID-Hu mouse skin organ culture Varicella-Zoster Virus [DOI] 10.1128/JVI.01082-20 PMC 바로가기
Skin Manifestations in COVID-19: Prevalence and Relationship with Disease SeverityArticle Published on 2020-10-122022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] Abnormalities Analysis analyzed Barcelona biopsy characteristic Characteristics chilblain clinical cohort of patient collected coronavirus COVID-19 Cutaneous disease exhibited Generalized histology Histopathology hospital ICU admission immunofluorescence immunohistochemistry lesion less lung infiltrate manifestation Other pandemic Patient patients patients with COVID-19 performed radiological relationship SARS-CoV-2 SARS-COV-2 infection severity of COVID-19 significantly skin skin biopsy skin lesions Spain study period systemic symptoms therapeutic [DOI] 10.3390/jcm9103261 PMC 바로가기 [Article Type] Article
Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patientsArticle Published on 2020-10-012023-07-06 Journal: Pathology, research and practice [Category] SARS, [키워드] coronavirus disease-2019 COVID-19 Diffuse alveolar damage histology pathology thrombotic microangiopathy Tissue biopsy. [DOI] 10.1016/j.prp.2020.153228 PMC 바로가기
Evaluation of K18- hACE2 Mice as a Model of SARS-CoV-2 InfectionArticles Published on 2020-09-282022-10-28 Journal: The American Journal of Tropical Medicine and Hygi [Category] COVID-19, SARS, [키워드] ACE2 alveolar biological pathway can be used clinical symptom Clinical symptoms COVID-19 Critical exhibited expressing hACE2 histology human ACE2 human Angiotensin-converting enzyme Infection inflammatory cell infiltration inoculated interstitial intranasally K18 lung mice Model receptor SARS-CoV-2 SARS-COV-2 infection scored septal thickening shown symptomatic SARS-CoV-2 infection the lungs a transgenic Transgenic mouse viral titer weight loss [DOI] 10.4269/ajtmh.20-0762 PMC 바로가기 [Article Type] Articles
Quantitative CT Extent of Lung Damage in COVID-19 Pneumonia Is an Independent Risk Factor for Inpatient Mortality in a Population of Cancer Patients: A Prospective StudyOncology Published on 2020-09-032022-10-31 Journal: Frontiers in Oncology [Category] COVID-19, [키워드] 95% CI Analysis association C-index Cancer cancer patient Cancer patients cancer stage Chest CT correlated COVID-19 COVID-19 pneumonia damage death demographic died distribution evaluate Evidence Factor Follow-up groups histology independent Inpatient IQR Laboratory lung lung damage lung lesion management median Mortality non-survivor oncology outcome Oxygen therapy Patient patients with COVID-19 performance status Pneumonia Population potential risk prognostic Prognostic factor prognostic performance Prospective Quantitative quantitative assessment quantitative chest CT extent released risk factor for mortality severity survival survivor Treatment was used were recorded [DOI] 10.3389/fonc.2020.01560 PMC 바로가기 [Article Type] Oncology
3D virtual pathohistology of lung tissue from Covid-19 patients based on phase contrast X-ray tomographyResearch Article Published on 2020-08-202022-10-31 Journal: eLife [Category] COVID-19, MERS, [키워드] 3d histology approach Autopsy characteristic COVID-19 cross DAD Diffuse alveolar damage distribution histology Histopathology Human hyaline membrane formation individual cells infiltrating interior lung tissue lymphocyte parenchymal pathophysiology Patient phase contrast quantification reconstructed tissue tissue remodeling tomography X-ray [DOI] 10.7554/eLife.60408 PMC 바로가기 [Article Type] Research Article
Germany’s first COVID-19 deceased: a 59-year-old man presenting with diffuse alveolar damage due to SARS-CoV-2 infectionBrief Report Published on 2020-07-042022-10-29 Journal: Virchows Archiv [Category] COVID-19, SARS, [키워드] acute respiratory distress affecting Atypical Autopsy change clinical Coagulation Computed tomography Concentration Corona Course COVID-19 COVID-19 patient Deceased described Diffuse alveolar damage displaying event feature histology identify incidence intern lung Micro-thrombosis Morphological morphological finding morphological findings morphology multinucleated cell Pathogenesis Pathomechanism performed presenting radiological reported SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RNA shown supplementary material syndrome the disease Tian unique [DOI] 10.1007/s00428-020-02872-y PMC 바로가기 [Article Type] Brief Report
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort studyResearch article Published on 2020-06-122022-10-05 Journal: The Lancet. Oncology [Category] SARS, 유전자 메커니즘, [키워드] 95% CI acute respiratory syndrome addition Admission admitted to ICU age Analysis Cancer Cardiopulmonary Chemotherapy chronic obstructive clinical Clinical characteristics Clinical outcome Cohort cohort study collaboration collected Comorbidities Comorbidity composed consecutive patient Cooperative coronavirus country Course COVID-19 COVID-19 diagnosis COVID-19 in patient criteria cross-sectional death demographics died eight eligible epithelial feature finding Follow-up funding General population global pandemic group high mortality high mortality rate histology hospitalised hypertension ICU admission increased risk Infection intensive care International Laboratory lung cancer Lung imaging majority median age medical record Mortality multicentre multivariable analysis multivariable logistic regression Neoplasms neuroendocrine Odds ratio Older Older age outcome pandemic Patient patient data patients Patients with cancer patients with COVID-19 performance status Pneumonia pulmonary disease receiving reduced RT-PCR SARS-CoV-2 Sex smoker smoking smoking status suggested susceptible Symptom Symptoms therapeutic options therapy Thoracic Thoracic malignancies Thoracic malignancy thought thymic Treatment Tumours univariable were measured WHO with COVID-19 [DOI] 10.1016/S1470-2045(20)30314-4 [Article Type] Research article
Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO ModelOncology Published on 2020-04-222022-10-31 Journal: Frontiers in Oncology [Category] COVID-19, [키워드] acute respiratory syndrome administration Admission anticancer applied benefit Better Cancer Care China clinical conditions Comorbidities concerning Containment containment measures Contamination coronavirus coronavirus disease country Course COVID-19 COVID-19 outbreak COVID-19 pandemic COVID-19 severity disease Elderly patient European expected Follow-up visit high risk histology hospital hospitals Infection International Interstitial lung disease Italy lung cancer lung cancer patient management measure media Model Mortality myelosuppression National Novel coronavirus oncologist oncology organization pandemic Patient Potential PROTECT pulmonary complication receiving recommendation reported required Result risk SARS-CoV-2 SARS-CoV2 infection significantly Spread suspected patient Symptom the disease Toxicity Treatment WHO with COVID-19 World Health Organization [DOI] 10.3389/fonc.2020.00665 PMC 바로가기 [Article Type] Oncology